Both WHO-HAEM5 and ICC also consider germline predisposition as disease qualifiers to the relevant AML subtype, e.g. AML with MR gene mutation, in the setting of germline RUNX1 mutation. Here, RUNX1 is linked to intrahepatic cholangiocarcinoma.